UK markets closed

Grifols, S.A. (0RDV.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
11.49-0.14 (-1.20%)
At close: 4:29PM BST
Full screen
Previous close11.62
Bid11.24 x 0
Ask11.73 x 0
Day's range11.42 - 11.51
52-week range11.42 - 16.80
Avg. volume31,470
Market cap11.125B
Beta (5Y monthly)0.10
PE ratio (TTM)11.85
EPS (TTM)0.97
Earnings dateN/A
Forward dividend & yield0.36 (3.07%)
Ex-dividend date03 Jun 2021
1y target estN/A
  • Reuters

    Spain's Grifols to buy rival Biotest for up to $1.9 billion

    MADRID (Reuters) -Spanish pharmaceuticals company Grifols proposed a 1.6 billion euro ($1.9 billion) takeover of its German rival Biotest on Friday, in a move to consolidate the plasma-based drug industry. Grifols said it had agreed with Tiancheng International Investment to buy the Hong Kong-based company's controlling stake in Biotest for 1.1 billion euros. The Barcelona-based company agreed to buy 89.88% of Biotest's ordinary shares that carry voting rights, but which represent only 44.54% of the company's capital, and a further 0.54% of capital in preferred shares that do not carry voting rights, from Hong Kong-based Tiancheng.